Exagen announces common stock offering, no amount given

Exagen (XGN) announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares of common stock to be sold in the offering will be sold by Exagen. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Canaccord Genuity is acting as sole bookrunner for the offering.